share_log

华海药业(600521.SH):托拉塞米注射液获药品注册证书

Huahai Pharmaceutical (600521.SH): Torasemide injection obtained drug registration certificate

Zhitong Finance ·  Mar 22 04:32

Huahai Pharmaceutical (600521.SH) announced that the company recently received the approval and issuance of Torasepam by the State Drug Administration...

Zhitong Finance App News, Huahai Pharmaceutical (600521.SH) announced that the company recently received the “Drug Registration Certificate” for torasemide injections approved and issued by the State Drug Administration. According to the announcement, torasemide injections are used to treat patients with edema caused by congestive heart failure, liver cirrhosis, ascites, and kidney disease who require rapid diuresis or cannot be taken orally.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment